Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Active Not Recruiting Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0109681 (Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs